Prostate Carcinoma

Oncology
3
Pipeline Programs
7
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
3
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

C
CureVacGermany - Tübingen
1 program
1
CV9104Phase 21 trial
Active Trials
NCT02140138TerminatedEst. Apr 2016
Blue Earth Therapeutics
1 program
1
Computed TomographyPhase 21 trial
Active Trials
NCT07185165RecruitingEst. Oct 2036
Alliance Pharmaceuticals
1 program
1
Oxybutynin ChloridePhase 21 trial
Active Trials
NCT04600336Completed88Est. Mar 2024
Knight Therapeutics
Knight TherapeuticsQC - Montréal
2 programs
Computer-Assisted InterventionN/A1 trial
Resistance TrainingN/A1 trial
Active Trials
NCT02869412Completed56Est. Jul 2017
NCT03741335Completed284Est. Jun 2024
One Biosciences
One BiosciencesFrance - Paris
1 program
Digital Image AnalysisN/A
EXACT Therapeutics
EXACT TherapeuticsNorway - Oslo
1 program
Digital Image AnalysisN/A1 trial
Active Trials
NCT04299620Active Not Recruiting86Est. Sep 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Blue Earth TherapeuticsComputed Tomography
Alliance PharmaceuticalsOxybutynin Chloride
CureVacCV9104
EXACT TherapeuticsDigital Image Analysis
Knight TherapeuticsResistance Training
Knight TherapeuticsComputer-Assisted Intervention

Clinical Trials (6)

Total enrollment: 514 patients across 6 trials

NCT07185165Blue Earth TherapeuticsComputed Tomography

An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.

Start: Oct 2025Est. completion: Oct 2036
Phase 2Recruiting
NCT04600336Alliance PharmaceuticalsOxybutynin Chloride

Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer

Start: Oct 2021Est. completion: Mar 202488 patients
Phase 2Completed
NCT02140138CureVacCV9104

An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer

Start: Jun 2014Est. completion: Apr 2016
Phase 2Terminated
NCT04299620EXACT TherapeuticsDigital Image Analysis

Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy

Start: Oct 2020Est. completion: Sep 202586 patients
N/AActive Not Recruiting
NCT03741335Knight TherapeuticsResistance Training

GET FIT Prostate: A Randomized Controlled Exercise Trial

Start: Feb 2019Est. completion: Jun 2024284 patients
N/ACompleted
NCT02869412Knight TherapeuticsComputer-Assisted Intervention

Computer-Based Behavior Change Guide in Increasing Physical Activity in Patients With Prostate Cancer Who Have Received Androgen Deprivation Therapy

Start: Jan 2015Est. completion: Jul 201756 patients
N/ACompleted

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
1h ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
1h ago

Office Administrator

SystImmune
1h ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
1h ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
1h ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
1h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 514 patients
7 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)